Description
Tri-Itra 100 SB (Itraconazole B.P. 100mg) capsules are specially developed using SUBA (Super Bio-Available) technology, which significantly improves the bioavailability of poorly soluble drugs. SUBA technology incorporates a solid dispersion of the drug in a polymer matrix, enhancing the dissolution and absorption of itraconazole in the body, providing a more effective treatment for fungal infections.
Itraconazole, a well-known antifungal agent, exhibits broad-spectrum activity against a wide range of fungal pathogens, including dermatophytes and yeasts. Tri-Itra 100 SB offers therapeutic benefits equivalent to a conventional 100 mg itraconazole capsule but with improved absorption, ensuring better patient compliance and treatment success.
Key Features:
- Enhanced SUBA technology for superior bioavailability.
- Equivalent to standard 100 mg itraconazole capsules.
- Broad-spectrum efficacy against fungal infections.
- Better patient compliance and acceptance compared to fluconazole.
Indications:
- Onychomycosis (fungal nail infections)
- Dermatophytosis (skin fungal infections)
- Tinea corporis, tinea cruris, tinea pedis
Tri-Itra 100 SB is ideal for treating various fungal infections with improved drug absorption and faster therapeutic results, offering a more reliable and effective solution for patients.